NovoCure Ltd (NVCR): Cash & Equivalents
$93.55M
As of 2025-12-31
$93.70M
As of 2026-06-30
-6.7%
3-year compound annual growth
-16.8%
5-year compound annual growth
-2.4%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $93.55M | -42.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $163.77M | -32.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $240.82M | +108.8% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $115.33M | -44.8% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $208.80M | -11.0% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $234.67M | +32.3% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $177.32M | +26.1% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $140.62M | +78.9% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $78.59M | -21.2% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $99.78M | -16.4% | 2018-02-22, Balance as of period end |
| 2015-12-31 | $119.42M | +107.3% | 2018-02-22, Balance as of period end |
| 2014-12-31 | $57.61M | -67.2% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $175.89M | n/a | 2016-03-01, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| NovoCure Ltd (NVCR) | 2025-12-31 | $93.55M | -42.9% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $20.30M | +50.9% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $236.01M | -43.8% |
| Bioventus Inc. (BVS) | 2025-12-31 | $51.24M | +23.2% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $160.81M | +15.8% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $167.43M | +36.4% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $82.03M | -1.5% |
| Glaukos Corp (GKOS) | 2025-12-31 | $90.81M | -46.5% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $104.81M | -30.2% |
Compare NVCR, UFPT, IRTC, BVS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗